Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects

被引:68
作者
Schneider, Harald Joern [1 ]
Saller, Bernhard
Klotsche, Jens
Maerz, Winfried
Erwa, Wolfgang
Wittchen, Hans-Ullrich
Stalla, Guenter Karl
机构
[1] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-8027 Dresden, Germany
[2] Max Planck Inst Psychiat, D-80804 Munich, Germany
[3] Pfizer GmbH, Karlsruhe, Germany
[4] Med Univ Graz, Inst Clin Chem, Graz, Austria
关键词
D O I
10.1530/eje.1.02131
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Insulin-like growth factor-1 (IGF-I) has been suggested to be a prognostic marker for the development of cancer and, more recently, cardiovascular disease. These diseases are closely linked to obesity, but reports of the association of IGF-I with measures of obesity are divergent. In this study, we assessed the association of age-dependent IGF-I standard deviation scores with body mass index (BMI) and intra-abdominal fat accumulation in a large population. Design: A cross-sectional, epidemiological study. Methods: IGF-I levels were measured with an automated chemiluminescence assay system in 6282 patients from the DETECT study. Weight, height, and waist and hip circumference were measured according to the written instructions. Standard deviation scores (SDS), correcting IGF-I levels for age, were calculated and were used for further analyses. Results: An inverse U-shaped association of IGF-I SDS with BMI, waist circumference, and the ratio of waist circumference to height was found. BMI was positively associated with IGF-I SDS in normal weight subjects, and negatively associated in obese subjects. The highest mean IGF-I SDS were seen at a BMI of 22.5-25 kg/m(2) in men (+0.08), and at a BMI of 27.5-30 kg/m(2) in women (+0.21). Multiple linear regression models, controlling for different diseases, medications and risk conditions, revealed a significant negative association of BMI with IGF-I SDS. BMI contributed most to the additional explained variance to the other health conditions. Conclusions: IGF-I standard deviation scores are decreased in obesity and underweight subjects. These interactions should be taken into account when analyzing the association of IGF-I with diseases and risk conditions.
引用
收藏
页码:699 / 706
页数:8
相关论文
共 34 条
[1]  
Ashwell M, 1996, BRIT MED J, V313, P559
[2]  
Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379
[3]   The insulin-like growth factor axis - A review of atherosclerosis and restenosis [J].
Bayes-Genis, A ;
Conover, CA ;
Schwartz, RS .
CIRCULATION RESEARCH, 2000, 86 (02) :125-130
[4]   Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system:: Results from a multicenter study [J].
Brabant, G ;
von zur Mühlen, A ;
Wüster, C ;
Ranke, MB ;
Kratzsch, J ;
Kiess, W ;
Ketelslegers, JM ;
Wilhelmsen, L ;
Hulthén, L ;
Saller, B ;
Mattsson, A ;
Wilde, J ;
Schemer, R ;
Kann, P .
HORMONE RESEARCH, 2003, 60 (02) :53-60
[5]   Plasma insulin-like growth factor I and prostate cancer risk: A prospective study [J].
Chan, JM ;
Stampfer, MJ ;
Giovannucci, E ;
Gann, PH ;
Ma, J ;
Wilkinson, P ;
Hennekens, CH ;
Pollak, M .
SCIENCE, 1998, 279 (5350) :563-566
[6]   Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors [J].
Clasey, JL ;
Weltman, A ;
Patrie, J ;
Weltman, JY ;
Pezzoli, S ;
Bouchard, C ;
Thorner, MO ;
Hartman, ML .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3845-3852
[7]   Optimizing GH therapy in adults and children [J].
Drake, WM ;
Howell, SJ ;
Monson, JP ;
Shalet, SM .
ENDOCRINE REVIEWS, 2001, 22 (04) :425-450
[8]   Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease [J].
Fischer, F ;
Schulte, H ;
Mohan, S ;
Tataru, MC ;
Köhler, E ;
Assmann, G ;
von Eckardstein, A .
CLINICAL ENDOCRINOLOGY, 2004, 61 (05) :595-602
[9]  
Frystyk J, 1999, DIABETES-METAB RES, V15, P314, DOI 10.1002/(SICI)1520-7560(199909/10)15:5<314::AID-DMRR56>3.3.CO
[10]  
2-5